News Feed Item

The Zacks Analyst Blog Highlights:JPMorgan, Pfizer, Coca-Cola, Johnson & Johnson and IBM

CHICAGO, April 21, 2014 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the JPMorgan (NYSE:JPM-Free Report), Pfizer Inc. (NYSE:PFE-Free Report), Coca-Cola Company (NYSE:KO-Free Report), Johnson & Johnson (NYSE:JNJ-Free Report) and IBM Corp. (NYSE:IBM-Free Report).

Zacks Investment Research, Inc., www.zacks.com

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

Here are highlights from Thursday's Analyst Blog:

Dow 30 Stock Roundup

The Dow notched up substantial gains during a holiday shortened week, boosted by several positive factors. Promising retail sales data propelled the blue chip index upward on Monday.

The Dow index gained again on Tuesday following upbeat quarterly results from key components. Encouraging industrial production numbers and China data egged on the blue chip index on Wednesday. Comments from the Fed Chair added to the positive sentiment. During the first three trading days, the Dow has gained 1.56%.

Last Week's Performance

The Dow dropped 0.9% last Friday, hit by another day of selling pressure in bio-tech and technology stocks. Disappointing corporate earnings also weighed on the markets.

Dismal corporate earnings results from JPMorgan (NYSE:JPM-Free Report) led the decline among the Dow components after its shares plunged 3.7%. Higher wholesale prices in March and an increase in preliminary consumer sentiment in April failed to restrict the day's losses.

For the week, the blue-chip index ended 2.3% lower, snapping a three-week run of gains. Benchmarks declined for the week due to intense selling pressure in momentum and technology stocks. Additionally, discouraging Chinese trade data unnerved investors.

Pfizer Inc. (NYSE:PFE-Free Report) was a big drag at the start of the week. The stock led the decline among the Dow components on Monday. Shares of the company were down almost 3% after its breast-cancer drug palbociclib did well in clinical trials but the overall survival benefits was not yet revealed to be statistically significant. However, on Wednesday, benchmarks soared, primarily boosted by encouraging minutes from the central bank's policy meeting.

The Dow Last Week

Encouraging retail sales data helped the Dow gain 0.9% on Monday. The U.S. Department of Commerce reported that seasonally adjusted sales of retail and food services rose 1.1% in March, its biggest gain since September 2012. The gain was led by the increase in demand for auto sales. Sales of motor vehicles jumped 3.1%, its biggest rise since September 2012. Investors also remained focused on recent developments in Ukraine.

The Dow gained 0.6% on Tuesday after blue-chip companies The Coca-Cola Company (NYSE:KO-Free Report) and Johnson & Johnson (NYSE:JNJ-Free Report) reported upbeat quarterly results. CPI improved 0.2% in March, higher than the consensus estimate of a 0.1% increase. The Empire State Manufacturing Index fell to 1.3 in April from 5.6 in March. This fall was in sharp contrast to the consensus estimate of a rise to 8.1. The day's mixed economic data had little impact on benchmarks.

Markets finished in the green on Wednesday, primarily boosted by encouraging industrial production data and better-than-expected Chinese economic data. Industrial production improved 0.7% in March after advancing 1.2% in February. Additionally, China's GDP increased 7.4% in the first quarter, more than the analysts' expectation of an increase by 7.3%. Fed Chairwoman Janet Yellen's speech in New York was another positive factor yesterday. The Dow gained substantially, by 1%.

Components Which Moved the Index

IBM Corp. (NYSE:IBM-Free Report) reported disappointing revenues in the first quarter of 2014, which missed the Zacks Consensus Estimate for the fifth straight quarter. However, earnings of $2.54 per share were in line with the Zacks Consensus Estimate.

Earnings per share declined 15.3% from the year-ago quarter and a massive 58.6% from the previous quarter due to lower revenue base and steep increase in total operating expenses.

The weaker-than-expected first-quarter results are expected to hurt IBM's ability to achieve fiscal 2014 earnings target of $18.00 per share. Shares declined 4.2% ($8.20) in after-hours trading yesterday.

The Coca-Cola Company started 2014 on a positive note, beating the Zacks Consensus Estimate for revenues in the first quarter while meeting earnings expectations as volumes gained slightly. This is the first time that Coca-Cola has beaten the Zacks Consensus Estimate for sales in the past six quarters. Shares were up 2% in pre-market trading on Tuesday.

First-quarter 2014 adjusted earnings came in at 44 cents per share, in line with the Zacks Consensus Estimate. Earnings declined 4% on a year-over-year basis due to currency headwinds as a strong dollar lowered the value of the company's ex-U.S. sales. Earnings grew 5% year over year on a constant currency basis as positive price/mix gains, strong developing market volumes and cost control made up for higher marketing costs.

Johnson & Johnson, the first among the large health care companies to report first quarter results, beat expectations yet again. The company's first-quarter 2014 earnings (excluding special items) were $1.54 per share, well above the Zacks Consensus Estimate of $1.48 per share and 6.9% above the year-ago earnings of $1.44 per share.

Despite the negative impact of currency fluctuation, Johnson & Johnson recorded growth on the back of strong pharma product sales. Johnson & Johnson's first quarter sales increased 3.5% year-over-year to $18.1 billion, just above the Zacks Consensus Estimate of $17.9 billion.

While operational factors favorably impacted sales by 5.3%, currency fluctuations had a negative impact of 1.8%.Including one-time items, Johnson & Johnson reported first quarter earnings of $1.64 per share, well above the year-ago earnings of $1.22.

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today.

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros.  In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros.

Get the full Report on JPM - FREE

Get the full Report on PFE - FREE

Get the full Report on KO - FREE

Get the full Report on JNJ - FREE

Get the full Report on IBM - FREE

Follow us on Twitter: http://twitter.com/zacksresearch

Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

[email protected]


Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Logo - http://photos.prnewswire.com/prnh/20101027/ZIRLOGO  

SOURCE Zacks Investment Research, Inc.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Daniel Jones is CTO of EngineerBetter, helping enterprises deliver value faster. Previously he was an IT consultant, indie video games developer, head of web development in the finance sector, and an award-winning martial artist. Continuous Delivery makes it possible to exploit findings of cognitive psychology and neuroscience to increase the productivity and happiness of our teams.
Poor data quality and analytics drive down business value. In fact, Gartner estimated that the average financial impact of poor data quality on organizations is $9.7 million per year. But bad data is much more than a cost center. By eroding trust in information, analytics and the business decisions based on these, it is a serious impediment to digital transformation.
The standardization of container runtimes and images has sparked the creation of an almost overwhelming number of new open source projects that build on and otherwise work with these specifications. Of course, there's Kubernetes, which orchestrates and manages collections of containers. It was one of the first and best-known examples of projects that make containers truly useful for production use. However, more recently, the container ecosystem has truly exploded. A service mesh like Istio addr...
As DevOps methodologies expand their reach across the enterprise, organizations face the daunting challenge of adapting related cloud strategies to ensure optimal alignment, from managing complexity to ensuring proper governance. How can culture, automation, legacy apps and even budget be reexamined to enable this ongoing shift within the modern software factory? In her Day 2 Keynote at @DevOpsSummit at 21st Cloud Expo, Aruna Ravichandran, VP, DevOps Solutions Marketing, CA Technologies, was jo...
Predicting the future has never been more challenging - not because of the lack of data but because of the flood of ungoverned and risk laden information. Microsoft states that 2.5 exabytes of data are created every day. Expectations and reliance on data are being pushed to the limits, as demands around hybrid options continue to grow.
Business professionals no longer wonder if they'll migrate to the cloud; it's now a matter of when. The cloud environment has proved to be a major force in transitioning to an agile business model that enables quick decisions and fast implementation that solidify customer relationships. And when the cloud is combined with the power of cognitive computing, it drives innovation and transformation that achieves astounding competitive advantage.
Digital Transformation: Preparing Cloud & IoT Security for the Age of Artificial Intelligence. As automation and artificial intelligence (AI) power solution development and delivery, many businesses need to build backend cloud capabilities. Well-poised organizations, marketing smart devices with AI and BlockChain capabilities prepare to refine compliance and regulatory capabilities in 2018. Volumes of health, financial, technical and privacy data, along with tightening compliance requirements by...
As IoT continues to increase momentum, so does the associated risk. Secure Device Lifecycle Management (DLM) is ranked as one of the most important technology areas of IoT. Driving this trend is the realization that secure support for IoT devices provides companies the ability to deliver high-quality, reliable, secure offerings faster, create new revenue streams, and reduce support costs, all while building a competitive advantage in their markets. In this session, we will use customer use cases...
The IoT Will Grow: In what might be the most obvious prediction of the decade, the IoT will continue to expand next year, with more and more devices coming online every single day. What isn’t so obvious about this prediction: where that growth will occur. The retail, healthcare, and industrial/supply chain industries will likely see the greatest growth. Forrester Research has predicted the IoT will become “the backbone” of customer value as it continues to grow. It is no surprise that retail is ...
Evan Kirstel is an internationally recognized thought leader and social media influencer in IoT (#1 in 2017), Cloud, Data Security (2016), Health Tech (#9 in 2017), Digital Health (#6 in 2016), B2B Marketing (#5 in 2015), AI, Smart Home, Digital (2017), IIoT (#1 in 2017) and Telecom/Wireless/5G. His connections are a "Who's Who" in these technologies, He is in the top 10 most mentioned/re-tweeted by CMOs and CIOs (2016) and have been recently named 5th most influential B2B marketeer in the US. H...
Andrew Keys is Co-Founder of ConsenSys Enterprise. He comes to ConsenSys Enterprise with capital markets, technology and entrepreneurial experience. Previously, he worked for UBS investment bank in equities analysis. Later, he was responsible for the creation and distribution of life settlement products to hedge funds and investment banks. After, he co-founded a revenue cycle management company where he learned about Bitcoin and eventually Ethereal. Andrew's role at ConsenSys Enterprise is a mul...
The best way to leverage your Cloud Expo presence as a sponsor and exhibitor is to plan your news announcements around our events. The press covering Cloud Expo and @ThingsExpo will have access to these releases and will amplify your news announcements. More than two dozen Cloud companies either set deals at our shows or have announced their mergers and acquisitions at Cloud Expo. Product announcements during our show provide your company with the most reach through our targeted audiences.
DevOpsSummit New York 2018, colocated with CloudEXPO | DXWorldEXPO New York 2018 will be held November 11-13, 2018, in New York City. Digital Transformation (DX) is a major focus with the introduction of DXWorldEXPO within the program. Successful transformation requires a laser focus on being data-driven and on using all the tools available that enable transformation if they plan to survive over the long term. A total of 88% of Fortune 500 companies from a generation ago are now out of bus...
With 10 simultaneous tracks, keynotes, general sessions and targeted breakout classes, @CloudEXPO and DXWorldEXPO are two of the most important technology events of the year. Since its launch over eight years ago, @CloudEXPO and DXWorldEXPO have presented a rock star faculty as well as showcased hundreds of sponsors and exhibitors! In this blog post, we provide 7 tips on how, as part of our world-class faculty, you can deliver one of the most popular sessions at our events. But before reading...
DXWorldEXPO LLC announced today that "Miami Blockchain Event by FinTechEXPO" has announced that its Call for Papers is now open. The two-day event will present 20 top Blockchain experts. All speaking inquiries which covers the following information can be submitted by email to [email protected] Financial enterprises in New York City, London, Singapore, and other world financial capitals are embracing a new generation of smart, automated FinTech that eliminates many cumbersome, slow, and expe...